# 21586-011-02 · Cefotaxime Sodium Powder, for Solution · SteriMax, Inc. — FDA drug shortage duration tracker

For 21586-011-02 · Cefotaxime Sodium Powder, for Solution · SteriMax, Inc., package ndc is 21586-011-02; generic name is Cefotaxime Sodium Powder, for Solution; manufacturer is SteriMax, Inc; status is Current; availability now is Available, recorded from its source on 2026-09-01.

- **Package NDC:** 21586-011-02 _(verified: appears in the quote below)_
- **Generic name:** Cefotaxime Sodium Powder, for Solution _(verified: appears in the quote below)_
- **Manufacturer:** SteriMax, Inc. _(verified: appears in its own passage below)_
- **Status:** Current _(verified: appears in its own passage below)_
- **Availability now:** Available _(verified: appears in the quote below)_
- **Initial posting date:** 02/17/2015 _(verified: appears in the quote below)_
- **Last update date:** 06/15/2026 _(verified: appears in its own passage below)_
- **Days in shortage:** 4214 _(our reading, not quoted from the source)_
- **Dosage form:** Powder, For Solution _(verified: appears in its own passage below)_
- **Therapeutic category:** Anti-Infective _(verified: appears in its own passage below)_

## What the source says

> "initial_posting_date": "02/17/2015", "package_ndc": "21586-011-02", "generic_name": "Cefotaxime Sodium Powder, for Solution", "related_info_link": "https://www.fda.gov/media/193116/download?attachment", "contact_info": "800-881-3550", "availability": "Available"

## Where each value comes from

This source states these in separate places, so each value is shown with the passage that states it.

### Manufacturer

> "update_date": "06/15/2026", "therapeutic_category": [ "Anti-Infective", "Pediatric" ], "dosage_form": "Powder, For Solution", "presentation": "Cefotaxime Sodium, Powder, for Solution, 1 g (NDC 21586-011-02)", "company_name": "SteriMax, Inc.", "status": "Current"

### Status

> "update_date": "06/15/2026", "therapeutic_category": [ "Anti-Infective", "Pediatric" ], "dosage_form": "Powder, For Solution", "presentation": "Cefotaxime Sodium, Powder, for Solution, 1 g (NDC 21586-011-02)", "company_name": "SteriMax, Inc.", "status": "Current"

### Last update date

> "update_date": "06/15/2026", "therapeutic_category": [ "Anti-Infective", "Pediatric" ], "dosage_form": "Powder, For Solution", "presentation": "Cefotaxime Sodium, Powder, for Solution, 1 g (NDC 21586-011-02)", "company_name": "SteriMax, Inc.", "status": "Current"

### Dosage form

> "update_date": "06/15/2026", "therapeutic_category": [ "Anti-Infective", "Pediatric" ], "dosage_form": "Powder, For Solution", "presentation": "Cefotaxime Sodium, Powder, for Solution, 1 g (NDC 21586-011-02)", "company_name": "SteriMax, Inc.", "status": "Current"

### Therapeutic category

> "update_date": "06/15/2026", "therapeutic_category": [ "Anti-Infective", "Pediatric" ], "dosage_form": "Powder, For Solution", "presentation": "Cefotaxime Sodium, Powder, for Solution, 1 g (NDC 21586-011-02)", "company_name": "SteriMax, Inc.", "status": "Current"

## Source

- https://api.fda.gov/drug/shortages.json?search=company_name%3A%22SteriMax,%20Inc.%22+AND+generic_name%3A%22Cefotaxime%20Sodium%20Powder,%20for%20Solution%22+AND+status%3A%22Current%22&limit=1000

Last verified: 2026-09-01. Review by: 2026-09-04.
Part of [FDA drug shortage duration tracker](https://referencesource.org/drug-shortage-duration-tracker/).